| Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ... Science 348 (6230), 124-128, 2015 | 8308 | 2015 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1860 | 2019 |
| Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma N van Rooij, MM van Buuren, D Philips, A Velds, M Toebes, B Heemskerk, ... Journal of Clinical Oncology 31 (32), e439-e442, 2013 | 965 | 2013 |
| Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers RS Andersen, P Kvistborg, TM Frøsig, NW Pedersen, R Lyngaa, ... Nature protocols 7 (5), 891-902, 2012 | 893 | 2012 |
| Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma CU Blank, EA Rozeman, LF Fanchi, K Sikorska, B van de Wiel, ... Nature medicine 24 (11), 1655-1661, 2018 | 785 | 2018 |
| Cancer neoantigens TN Schumacher, W Scheper, P Kvistborg Annual review of immunology 37 (1), 173-200, 2019 | 521 | 2019 |
| Anti–CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response P Kvistborg, D Philips, S Kelderman, L Hageman, C Ottensmeier, ... Science translational medicine 6 (254), 254ra128-254ra128, 2014 | 435 | 2014 |
| Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ... Cell 183 (3), 818-834. e13, 2020 | 388 | 2020 |
| Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer S Krishna, FJ Lowery, AR Copeland, E Bahadiroglu, R Mukherjee, L Jia, ... Science 370 (6522), 1328-1334, 2020 | 385 | 2020 |
| Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial N van Dijk, A Gil-Jimenez, K Silina, K Hendricksen, LA Smit, JM de Feijter, ... Nature medicine 26 (12), 1839-1844, 2020 | 324 | 2020 |
| Phase II study of autologous monocyte-derived mRNA electroporated dendritic cells (TriMixDC-MEL) plus ipilimumab in patients with pretreated advanced melanoma S Wilgenhof, J Corthals, C Heirman, N van Baren, S Lucas, P Kvistborg, ... Journal of Clinical Oncology 34 (12), 1330-1338, 2016 | 315 | 2016 |
| The cancer antigenome B Heemskerk, P Kvistborg, TNM Schumacher The EMBO journal 32 (2), 194-203, 2013 | 298 | 2013 |
| Identification of bacteria-derived HLA-bound peptides in melanoma S Kalaora, A Nagler, D Nejman, M Alon, C Barbolin, E Barnea, ... Nature 592 (7852), 138-143, 2021 | 278 | 2021 |
| Novel technologies and emerging biomarkers for personalized cancer immunotherapy J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ... Journal for immunotherapy of cancer 4, 1-25, 2016 | 273 | 2016 |
| Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option MW Rohaan, JH van den Berg, P Kvistborg, JBAG Haanen Journal for immunotherapy of cancer 6 (1), 102, 2018 | 245 | 2018 |
| High-throughput identification of antigen-specific TCRs by TCR gene capture C Linnemann, B Heemskerk, P Kvistborg, RJC Kluin, DA Bolotin, X Chen, ... Nature medicine 19 (11), 1534-1541, 2013 | 227 | 2013 |
| TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients P Kvistborg, CJ Shu, B Heemskerk, M Fankhauser, CA Thrue, M Toebes, ... Oncoimmunology 1 (4), 409-418, 2012 | 211 | 2012 |
| The Human Vaccines Project: A roadmap for cancer vaccine development P Romero, J Banchereau, N Bhardwaj, M Cockett, ML Disis, G Dranoff, ... Science translational medicine 8 (334), 334ps9-334ps9, 2016 | 188 | 2016 |
| mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ... The Lancet Oncology 22 (12), 1681-1691, 2021 | 161 | 2021 |
| Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up JH van den Berg, B Heemskerk, N van Rooij, R Gomez-Eerland, ... Journal for immunotherapy of cancer 8 (2), 2020 | 135 | 2020 |
